<DOC>
	<DOCNO>NCT00896350</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , functional MRI , may help measure oxygen level tumor cell may help plan cancer treatment . PURPOSE : This phase I trial study functional MRI see well work find hypoxia patient undergo chemotherapy radiation therapy stage III stage IV head neck cancer .</brief_summary>
	<brief_title>Functional MRI Finding Hypoxia Patients Undergoing Chemotherapy Radiation Therapy Stage III Stage IV Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine undertaken oxygen sensitive MRI detection hypoxia patient Stage III-IV head neck cancer . - Correlate MRI parameter histology , gene expression , plasma osteopontin . - Correlate tumor hypoxia measurement patient prognosis treatment response . OUTLINE : - Pre-therapy MRI : Patients undergo blood oxygen level dependant ( BOLD ) contrast MRI room air breathe 2 minute oxygen gas 15 minute . Patients also undergo MR-spectroscopy 15 minute measure choline lactate marker , dynamic contrast MRI gadolinium contrast 8 minute . - Chemoradiotherapy : Patients receive platinum base chemotherapy every two week . Patients also undergo radiation therapy 6 week . - Post-radiation MRI : Patients undergo MRI chemoradiotherapy . Blood tumor sample collect baseline biomarker analysis associate tumor progression response . After completion study , patient follow every 3 month 1 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma head neck Stage III IV disease Measurable disease Scheduled undergo standard treatment include radiation therapy chemotherapy Participation study # 092004010 tissue procurement PATIENT CHARACTERISTICS : ECOG performance status 02 Serum creatinine ≤ 1.5 OR creatinine clearance ≥ 40 Body mass index ≤ 34 Kg/m^2 Not claustrophobic No contraindication MRI ( i.e. , implant pacemaker device ) Not pregnant nursing Negative pregnancy test No allergy gadolinium PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III lymphoepithelioma nasopharynx</keyword>
	<keyword>stage III lymphoepithelioma oropharynx</keyword>
	<keyword>stage III verrucous carcinoma larynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma oropharynx</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>stage III basal cell carcinoma lip</keyword>
	<keyword>stage IV basal cell carcinoma lip</keyword>
	<keyword>stage III esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage III midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>tongue cancer</keyword>
</DOC>